Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages  

作　　者：Antonio Giorgio Massimo De Luca 

机构地区：[1]Athena Clinic Center,Via Matese,Piedimonte Matese(CE)81016,Campania,Italy [2]Liver Unit,AORN Cardarelli,Via A.Cardarelli,Napoli 80131,Campania,Italy

出　　处：《World Journal of Clinical Cases》2024年第28期6241-6243,共3页世界临床病例杂志

摘　　要：This manuscript is based on a case reported by Song et al published in the World Journal of Clinical Cases.Several challenges remain in the field of hepatocellular carcinoma(HCC)conversion therapy.Consequently,only a limited number of patients with HCC accompanied by portal vein tumor thrombosis(PVTT)and hepatic vein tumor thrombosis(HVTT)are eligible for resection.This clinical case demonstrates that considering the complexity of the disease,a multimodal and multidisciplinary approach is essential for managing HCC accompanied by PVTT and HVTT.However,the outcomes of such surgeries remain controversial.In conclusion,research on HCC conversion therapy is extremely useful for impro-ving treatment strategies for intermediate and advanced HCC,which currently have disappointing clinical outcomes.

关 键 词：Hepatocellular carcinoma Portal vein Inferior vena cava Tumor thrombus Conversion surgery 

分 类 号：R735.7[医药卫生—肿瘤]